Company intelligence

ACRV

Acrivon Therapeutics, Inc. Common Stock · NASDAQ · Healthcare

Price$1.81+7.10% · +$0.12

Market cap77.56MEquity value

P / E-1.0Trailing ratio

Volume101.46KLatest session

Market data

ACRV price chart

TradingView

Related signals

1 min delayed

Browse public ACRV signals with their source context and measured market impact. Open any signal for its permanent analysis page.

ACRVMay 10, 2024+4.90% since signal

Is a Surprise Coming for Acrivon Therapeutics (ACRV) This Earnings Season?

- Acrivon Therapeutics may beat earnings, seeing positive earnings estimate revisions. - Current quarter estimate is narrower than Zacks Consensus Estimate. - Positive Zacks Earnings ESP indicates potential market outperformance for ACRV. - Analysts raising ACRV estimates before earnings may lead to positive surprise. - Consider investing in ACRV ahead of earnings based on recent revisions. Price Impact Rating: bullish Impact Horizon Rating: short-term Type: Research Analysis

View signal analysis

ACRVApr 24, 2024

Acrivon Therapeutics' shares climb 14% on plans to present cancer-test data

- Acrivon Therapeutics will present clinical trial data for ovarian and endometrial cancers. Price Impact Rating: bullish Impact Horizon Rating: short-term Type: Corporate Developments

View signal analysis

Research